Endocrine Research Updates

For Medical Professionals

The best treatment for people with obesity and diabetes is bariatric surgery.
Given the surging rates of diabetes, hypertension, cardiovascular disease, and obesity-related cancers, the time has arrived for clinicians to address bariatric surgery as an appropriate option for many patients.
Risk of autoimmune diseases, such as diabetes, increased by Epstein-Barr virus.
Researchers uncover genetic link involving b cells that suggest an increased risk of developing at least seven identified autoimmune disorders, including type 1 diabetes, following a person's infection with the Epstein-Barr virus.
Researchers find underlying cause of treatment failure for standard BP care.
Researchers uncovered excess aldosterone as cause of antihypertensive treatment failure, and shed light on mechanisms to support breakthrough treatment success in resistant hypertension.
Breakthrough in understanding of resistant hypertension points to hormone imbalance as the reason for failure to respond to standard blood pressure treatment.
Women with PCOS may have hypothryoidism which have implications for pregnancy.
Women with polycystic ovary syndrome appear at increased risk for comorbid thyroid disorders, yet a study by researchers from the Cleveland Clinic introduced more questions about pregnancy outcomes.
Diabetes care is now achieving Integrated Continuous Glucose Monitoring.
A round-up of recent diabetes products and updated innovations and indications considered by the Food and Drug Administration, highlighting the first integrated CGM and first implantable glucose sensor.
Seeking new biomarker to identify greater diabetes risk for heart disease.
Evaluating a possible role for FGF-23 in CHD, accounting for differences in race, sex, and chronic kidney disease status from a subset of the REGARDS data
Evaluating a possible role for fibroblast growth factor-23 in CHD, accounting for differences in race, sex, and chronic kidney disease status from a subset of the REGARDS data
Innovations in diabetes care explode with 3 new diabetes products introduced.
March brings 3 diabetes product innovations, a clinician office task organizer app, and a warning about patient perceptions regarding attatins: they don't need them.
Patients will benefit from less intensive treatment to reduce hemoglobin A1c.
Need for intensive drug treatment to reduce hemoglobin A1C targets called into question by the American College of Physicians but defended by the leading endocrine-related organizations, placing clinicians in the middle of debate over T2D treatment.
American College of Physicians updated treatment guideline for type 2 diabetes recommends less intensive treatment to promote benefits and avoid evident harms.
In-office device enables earlier screening for common eye disease in diabetes.
The ability to assess eye health in patients with diabetes can begin with an in-office screening using artificial intelligence software, accelerating referral to an ophthalmologist for earlier treatment.
Brief overview of revised recommendations on use of hormones in postmenopausal women, and on care of chronic kidney disease-mineral bone disorder, and lifestyle factors your patients still need to hear.
Survival is not affected by thyroid tumors of less than 2.5 cm.
Duke University research team reported no need to biopsy thyroid nodules measuring less than 2.5 cm since there is no apparent effect on survival.
Lipid guidelines can inform treatment, but should be individualized.
Given so many guidelines for hyperlipidemia, the best approach is individualizing care, informed by evidence-based treatment recommendations.
Diabetes drug approvals, medication launches, and diabetes practice guidelines.
EndocrineWeb features highlights of recent government activities, new product announcements, and brief study findings to keep you informed of advances in diabetes care management.
Screening and treatment for osteoporosis is essential to avoid bone fractures.
With hip fractures rates on the rise, a concerted effort is needed to revisit regular bone screenings, and bisphosphonate treatment including education about the reality of side effects.
Patients with diabetes benefit from newly introduced apps and devices to support
Quick overview of new medical device regulations, devices, and software to inform your practice and may be of interest to trial with your patients.
Obesity in metabolic disease is due to poor mitochondrial function.
Implications for intransigent obesity may be related first to your patients’ metabolic inflexibility and only secondarily to their diet, and may offer an early warning sign of diabetes. .
Proposed new guidelines challenge current recommendations to improve management
Peer-reviewed recommendations to change the diagnosis criteria and treatment considerations for thyroid storm reflect observed patient experiences that go beyond current common sense practices.
Eating more mindfully and increasing physical activity will reduce CVD risk.
Addressing behaviors such as diet, physical activity, weight, and smoking appear to mediate development of cardiovascular disease in women who had gestational diabetes.
Harvard researchers present evidence that low TSH adversely affects fertility.
Slightly low thyroid stimulating hormone levels may offer a reason why some women struggle to get pregnant suggest Harvard researchers.
PCOS puts women at twice the risk for non-alcoholic fatty liver disease.
PCOS puts women at increased risk for steatosis and fibrosis with insulin resistance and hyperandrogenism as key factors in liver damage of these patients.